International Bio Recovery Corporation
TSX VENTURE : IBR

International Bio Recovery Corporation

December 20, 2010 15:39 ET

IBR Announces New Director and Options

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 20, 2010) -

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES

International Bio Recovery Corporation ("IBR") (TSX VENTURE:IBR), a developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, announces that Dirk Schillebeeckx has been appointed as a director of the Company.

Mr. Schillebeeckx has extensive experience working for high technology companies in senior management roles and more recently working with small cap technology companies. For the past 20 years, he has assisted several early growth stage companies through the development stage to commercial success. He is currently founder and CEO of a software company based in Burnaby, British Columbia. Dirk has an economics degree from the University of Montreal.

The Company has also granted 2,025,000 stock options to employees and directors. The options may be exercised at $0.12 per share until expiry in five years; 25% of the options vest immediately and an additional 25% every six months thereafter.

About IBR

Located in North Vancouver, BC, IBR is committed to research and development to continue to improve the efficiency of its technology and the quality of Genica branded agricultural products. It is further committed to developing a world wide marketing capability to ensure market acceptance of the Genica products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although IBR believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of IBR's management on the date the statements are made. Except as required by law, IBR undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • International Bio Recovery Corporation
    Blair Heffelfinger
    President & CEO
    (604) 924-1023 ext 316
    (604) 924-1043 (FAX)
    bheffelfinger@ibrcorp.com
    or
    International Bio Recovery Corporation
    Bob Nowell
    CFO & Corporate Secretary
    (604) 924-1023 ext 306
    (604) 924-1043 (FAX)
    bnowell@ibrcorp.com